Krystal Biotech buy Citigroup Inc.
Start price
12.01.26
/
50%
€233.70
Target price
12.01.27
€288.19
Performance (%)
34.27%
Price
16:26
€313.80
Summary
This prediction is currently active. With a performance of 34.27% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 12.01.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 4.276% | 4.276% |
| iShares Core DAX® | 2,99 % | 3,22 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % |
| iShares S&P 500 | -0,01 % | 1,64 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Citigroup Inc. from $320.00 to $336.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
